Ties between India & the US have hit a rough patch in recent months. Trump imposed tariffs of 50 percent on India for its unfair trade practices & continued purchase of Russian oil.
Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS